DTC
BCYC

Deep Track Capital’s Bicycle Therapeutics BCYC Stock Holding History

Deep Track Capital’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,203,244
Closed -$8.36M – 58
2025
Q2 		$8.36M Buy
1,203,244
+436,228
+57% +$3.47M 0.27% 45
2025
Q1 		$6.51M Sell
767,016
-509,065
-40% -$6M 0.21% 54
2024
Q4 		$17.9M Sell
1,276,081
-2,271,920
-64% -$48.7M 0.67% 39
2024
Q3 		$80.3M Buy
3,548,001
+57,495
+2% +$1.33M 2.55% 16
2024
Q2 		$70.6M Hold
3,490,506
– – 2.11% 19
2024
Q1 		$86.9M Hold
3,490,506
– – 2.49% 18
2023
Q4 		$63.1M Hold
3,490,506
– – 2.11% 19
2023
Q3 		$70.1M Buy
3,490,506
+671,461
+24% +$15.4M 2.71% 13
2023
Q2 		$71.9M Hold
2,819,045
– – 3.33% 13
2023
Q1 		$60M Hold
2,819,045
– – 2.46% 16
2022
Q4 		$83.4M Sell
2,819,045
-80,955
-3% -$2.17M 3.5% 7
2022
Q3 		$67.5M Hold
2,900,000
– – 3.09% 9
2022
Q2 		$48.7M Buy
2,900,000
+1,044,007
+56% +$22M 3.2% 11
2022
Q1 		$81.4M Buy
1,855,993
+755,993
+69% +$35.3M 5.22% 2
2021
Q4 		$67M Buy
+1,100,000
New +$60.7M 4.73% 3

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Deep Track Capital's BCYC Position: Q3 2025 in Review

Deep Track Capital sold out of Bicycle Therapeutics (BCYC) in Q3 2025, closing a stake of 1,203,244 shares — an estimated $8.36M sold.

Deep Track Capital first reported a position in BCYC in Q4 2021 and held it in 15 quarters. The position peaked at $86.9M in Q1 2024. 99 funds tracked by Wall St. Rank hold BCYC as of Q3 2025.

  • Deep Track Capital reported no remaining Bicycle Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Deep Track Capital sold 1,203,244 Bicycle Therapeutics shares in Q3 2025, an estimated $8.36M.
  • Deep Track Capital first reported a position in Bicycle Therapeutics in Q4 2021 and held it in 15 quarters.
  • Deep Track Capital's Bicycle Therapeutics position peaked at $86.9M in Q1 2024.
  • 99 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2025.

Based on Deep Track Capital's 13F filing for Q3 2025, filed 14 Nov 2025.